Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028623 · ClinicalTrials.gov registry record · NA
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
A NA study of Method of Tubal Ligation at the Time of Cesarean Section, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03028623: Completed NA study of Method of Tubal Ligation at the Time of Cesarean Section, sponsored by University of Virginia.
NCT03028623 is a NA study of Method of Tubal Ligation at the Time of Cesarean Section that has completed, run by University of Virginia. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028623, a NA study of Method of Tubal Ligation at the Time of Cesarean Section, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established. This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.
Primary Outcome
Primary outcome will be the time it takes to complete the sterilization procedure
Conditions Studied
Interventions
- PROCEDURE Salpingectomy
- PROCEDURE Tubal ligation
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-05 |
| Phase | NA |
What the finished NCT03028623 record still lists
NCT03028623 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Method of Tubal Ligation at the Time of Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Salpingectomy is the first listed.
NCT03028623 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03028623 about?
NCT03028623 is a clinical study titled "Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery". The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer preven...
What is the current status of trial NCT03028623?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-05-01. Estimated completion is 2018-03-05.
What conditions does trial NCT03028623 study?
This clinical trial studies the following conditions: Method of Tubal Ligation at the Time of Cesarean Section.
What interventions are being tested in trial NCT03028623?
The interventions under investigation include: Salpingectomy (PROCEDURE), Tubal ligation (PROCEDURE).
Who is sponsoring clinical trial NCT03028623?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028623 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03028623's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI